Statistics

Total Visits

Views
Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The29

Select a period of time:

Number of views in the range

Views
Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The3

Views

Views
June 20250
July 20250
August 20250
September 20253
October 20250
November 20250
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
 

Top cities views

Views
Dallas3